Academic Jobs Logo

Ulster University Joins £1.7m UK Study Probing Plant Foods' Impact on Heart Health

Key Insights from the BBSRC-Funded Cardiovascular Nutrition Project

Be the first to comment on this article!

You

Please keep comments respectful and on-topic.

a close up of a plant with a heart shaped object in the background
Photo by Elin Melaas on Unsplash

Promote Your Research… Share it Worldwide

Have a story or a research paper to share? Become a contributor and publish your work on AcademicJobs.com.

Submit your Research - Make it Global News

Ulster University Researchers Embark on Groundbreaking £1.7m Project

Researchers from Ulster University's Coleraine campus have joined a prestigious £1.7 million UK-wide study funded by the Biotechnology and Biological Sciences Research Council (BBSRC). This four-year initiative, led by King's College London, aims to unlock the mysteries of how plant-based foods influence cardiovascular health. Collaborating with the University of Leeds, the project zeroes in on flavan-3-ols—naturally occurring compounds abundant in everyday foods like tea, cocoa, berries, apples, grapes, nuts, and legumes.

Cardiovascular disease (CVD), encompassing conditions like coronary heart disease and stroke, remains the UK's leading cause of death. According to the British Heart Foundation's Heart & Circulatory Disease Statistics 2025, CVD accounts for around one in six deaths, equating to approximately 110,000 fatalities annually—or one every five minutes. With over 7.6 million people living with heart and circulatory diseases, innovative research into dietary interventions is more critical than ever.

Understanding Flavan-3-ols: Key Players in Plant Foods

Flavan-3-ols are a subclass of flavonoids, potent antioxidants found predominantly in plant-derived foods. These bioactive compounds contribute to the characteristic flavors, colors, and health-promoting properties of items like green tea, dark chocolate, and fresh fruits. Unlike vitamins or minerals, their concentrations can vary significantly based on food processing, storage, and even chewing habits.

Existing evidence from systematic reviews and meta-analyses indicates that flavan-3-ols improve endothelial function—the health of blood vessel linings—and lower blood pressure, key factors in reducing CVD risk. For instance, a comprehensive analysis of randomized controlled trials showed flavan-3-ol-rich interventions significantly enhance flow-mediated dilation, a marker of vascular health.

Assortment of plant foods rich in flavan-3-ols including tea, berries, apples, and nuts

The Cardiovascular Burden in the United Kingdom

In the UK, CVD prevalence continues to rise, particularly among younger adults under 65, where deaths have increased by 18% since 2019. Lifestyle factors, including diet, play a pivotal role, with poor nutrition contributing to high cholesterol, hypertension, and obesity. Plant-based diets, rich in fiber, antioxidants, and polyphenols like flavan-3-ols, have shown promise in mitigating these risks. Studies suggest healthful plant-based eating patterns can reduce CVD incidence by 19-25%.

Northern Ireland, home to Ulster University, faces similar challenges, with heart disease rates higher than the UK average. This underscores the timeliness of the new study, which could inform targeted public health strategies.

Ulster University's Pivotal Role in the Research

Ulster University, through its Nutrition Innovation Centre for Food and Health (NICHE), brings world-class expertise to the project. Professor Chris Gill, a co-lead investigator and thematic leader for Phytochemicals in Health and Diseases at NICHE, will spearhead human trials using volunteers with ileostomies—surgical openings that bypass the lower gut. This innovative approach allows precise examination of upper gastrointestinal (GI) tract digestion of flavan-3-ols, revealing how these compounds are released and absorbed before reaching the colon.

"The importance of flavan-3-ols and other (poly)phenols to human health continues to evolve," says Professor Gill. "Understanding how these compounds are affected by food processing and the human digestive tract is key to developing a mechanistic understanding of their biological efficacy."

Professor Chris Gill: A Leader in Polyphenol Research

With extensive publications on polyphenols' impact on gut health and endothelial function, Professor Gill's work at Ulster has illuminated how dietary compounds interact with the microbiome to support cardiovascular wellness. His recent reviews highlight (poly)phenol-rich foods' role in improving flow-mediated dilation, a direct measure of vascular health.

  • Expertise in phytochemical bioaccessibility and bioavailability.
  • Leadership in NICHE, driving translation from lab to policy.
  • Collaborations advancing personalized nutrition.

Collaborative Excellence: Partners and Methods

King's College London, under Professor Ana Rodriguez-Mateos, leads with advanced analytical techniques to build a UK flavan-3-ol database. The University of Leeds contributes 'AVATAR' models—personalized gut microbiome simulations cultured from fecal samples—to study individual responses. This multi-faceted approach combines lab models, clinical trials, and population data for robust insights.

The project addresses critical gaps: why do people respond differently to the same foods? How does processing alter bioactivity? Outcomes could personalize dietary advice, optimizing flavan-3-ol intake at 400-600mg daily for benefits.

Innovative Techniques Revolutionizing Nutrition Science

MethodPurposeLead Institution
Ileostomy trialsUpper GI digestion analysisUlster University
AVATAR microbiome modelsPersonalized gut responsesUniversity of Leeds
Food composition databaseUK intake estimatesKing's College London
Clinical intervention trialCardiometabolic effectsAll partners

These tools promise unprecedented precision, bridging food science and clinical outcomes.

Building on Prior Evidence: Plant Foods and CVD Prevention

Meta-analyses confirm flavan-3-ols from cocoa and tea reduce systolic blood pressure by 2-4mmHg and enhance endothelial function. Healthful plant-based diets correlate with 16-31% lower CVD risk, emphasizing minimally processed sources. Ulster's NICHE has pioneered such findings, influencing global nutrition policy.

Public Health Implications and Future Dietary Guidance

Results could refine UK Eatwell Guide recommendations, promoting flavan-3-ol-rich foods to combat rising CVD. Personalized nutrition, informed by gut microbiome data, may tailor diets for high-risk groups. For Northern Ireland, enhanced research capacity via the £22m Centre of Food and Drug Discovery will accelerate industry collaborations.

Explore the full study details at the Ulster University announcement or King's College London page.

Advancing Higher Education and Research Careers

This project exemplifies UK higher education's role in addressing grand challenges. Ulster's involvement highlights opportunities in nutrition innovation, attracting funding and talent. Aspiring researchers can pursue PhDs in NICHE, focusing on phytochemicals and gut health.

Researchers at Ulster University's Nutrition Innovation Centre conducting food health trials

With BBSRC backing, such initiatives bolster university profiles, fostering interdisciplinary careers in biomedical sciences.

a pile of food

Photo by Immo Wegmann on Unsplash

Looking Ahead: Transforming Heart Health Through Science

As the study unfolds over four years, expect breakthroughs that empower individuals with actionable dietary insights. By demystifying plant foods' journey through the body, this collaboration could save lives, reduce NHS burdens, and position UK universities as global leaders in preventive nutrition.

Portrait of Prof. Clara Voss

Prof. Clara VossView full profile

Contributing Writer

Illuminating humanities and social sciences in research and higher education.

Acknowledgements:

Discussion

Sort by:

Be the first to comment on this article!

You

Please keep comments respectful and on-topic.

New0 comments

Join the conversation!

Add your comments now!

Have your say

Engagement level

Browse by Faculty

Browse by Subject

Frequently Asked Questions

❤️What is the main focus of the £1.7m UK study involving Ulster University?

The study investigates how digestion and processing of plant foods, particularly flavan-3-ols from tea, cocoa, berries, and nuts, influence cardiovascular health. It aims to provide the first validated UK intake estimates and test personalized responses.

🍎What are flavan-3-ols and their sources?

Flavan-3-ols are flavonoid antioxidants in plant foods like apples, grapes, berries, nuts, legumes, tea, and cocoa. They support blood vessel function and lower blood pressure. See this review for evidence.

🔬How does Ulster University contribute to the project?

Led by Professor Chris Gill, Ulster conducts trials with ileostomy volunteers to study upper GI digestion of flavan-3-ols, leveraging NICHE's expertise in phytochemical bioactivity.

📊What is the CVD burden in the UK?

CVD causes ~110,000 deaths yearly (1 in 6), with 7.6m living affected. Deaths in under-65s rose 18% since 2019 per BHF 2025 stats.

🧪What methods make this study innovative?

Includes AVATAR personalized gut models, stoma trials, and comprehensive food databases for precise bioavailability analysis.

💓What health benefits do flavan-3-ols offer?

Meta-analyses show reduced BP, improved endothelial function, and lower CVD risk at 400-600mg daily intake.

🤝Who are the key partners and leaders?

King's College London (Prof. Ana Rodriguez-Mateos, lead), Ulster (Prof. Chris Gill, co-lead), Leeds (Prof. Kieran Tuohy, co-lead).

🍽️How might results impact dietary guidelines?

Could refine UK recommendations, promoting flavan-3-ol-rich foods for personalized heart health strategies.

🏛️What is NICHE at Ulster University?

Nutrition Innovation Centre for Food and Health drives research linking diet to health, with global policy impact.

🎓Are there career opportunities in this field?

Yes, PhDs and research roles in nutrition, biomedical sciences at Ulster and UK universities.

When does the study conclude?

It's a four-year project starting around 2026, with findings expected to shape future health policies.